Medical Device / MedTech

Banner Capital Rolls Up Three Plastics Makers for Medical Device Platform

Dealroom.co reports Banner Capital has agreed to acquire three plastics makers’ businesses for a new medical device platform.

By ROOK Industry News
Plastics manufacturing components for a medical device platform

Banner Capital has agreed to acquire the businesses of three plastics makers for a new medical device platform, according to Dealroom.co.

Reported transaction

Dealroom.co characterizes the agreement as a roll-up of three plastics makers. The businesses are to be brought together in a new medical device platform under Banner Capital.

The supplied report identifies Banner Capital as the party agreeing to acquire the businesses and identifies the intended result as a medical device platform. It does not provide further details about the businesses involved or the transaction terms.

Medical device sales context

For medical device sales professionals, the announcement concerns the formation of a platform built around plastics makers. Dealroom.co’s report places the transaction within the medical device sector through the planned platform.

The available evidence does not describe products, customers, commercial operations, sales channels, supplier arrangements, or the structure of the platform beyond the reported roll-up. It also does not provide details on timing beyond the published report.

Sales teams following medical device manufacturing and related businesses can view the agreement as a reported ownership and platform-development event. Any conclusions about product portfolios, customer relationships, commercial coverage, or operating plans would go beyond the information supplied by Dealroom.co.

What Dealroom.co reported

  • Banner Capital agreed to acquire the businesses of three plastics makers.
  • Dealroom.co described the transaction as a roll-up.
  • The acquisitions are intended to create a new medical device platform.

Dealroom.co’s report focuses on the agreement and the planned platform. Additional information on the parties, deal structure, and platform operations was not included in the supplied evidence.

Sources